- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Arrhythmia
The Practical Cardiology™ Arrhythmia clinical resource center provides information and insights for those interested in the latest from the field of heart rhythm disorders. From atrial fibrillation to ventricular tachycardia and everything in between, this page is where readers can find articles, videos, podcasts, and conference coverage related to arrhythmias and electrophysiology.
ESC Congress 2021 Expert Perspective: Top 5 Studies With Brett Nowlan, MD
September 02, 2021
Practical Cardiology editorial advisory board member Brett Nowlan, MD, compiled a top 5 list of studies he thought were noteworthy from ESC Congress 2021 and offers his perspective on why he chose each study.
ENVISAGE-TAVI AF: Clinical Implications and Next Steps, With George Dangas, MD, PhD
August 31, 2021
George Dangas, MD, PhD, discusses the results of ENVISAGE-TAVI AF and provides perspective into the priorities of investigators as they plan and conduct additional analyses of the trial.
Amplatzer Amulet Outperforms Watchman Device for LAA Occlusion in Head-to-Head Trial
August 30, 2021
The Amulet IDE Trial is the first trial to offer a head-to-head comparison of the Amplatzer Amulet occluder from Abbot against the Watchman device from Boston Scientific for left atrial appendage occlusion.
In High-Risk Patients, Most DOACs Reduce Stroke Risk Without Increasing Bleeding Risk vs Warfarin
August 16, 2021
Using propensity score-matching, a new study is providing insight into the risk reduction and bleeding risk associated with various DOACs versus warfarin and one another in patients with nonvalvular atrial fibrillation and an increased gastrointestinal bleeding risk.
Watchman Implant Procedures Carry Greater Adverse Event Risk in Women, Analysis Finds
August 11, 2021
An analysis of the NCDR LAAO Registry suggests women had longer hospital stays and a greater risk of adverse events following implant of the Watchman device than their male counterparts.
No Evidence Coffee Consumption Increases Risk of Arrhythmias, UCSF Study Finds
July 20, 2021
Analysis of data from the UK Biobank cohort suggests consumption of coffee was not linked to an increased risk of arrhythmias, with some evidence indicating habitual use was linked to a decrease in incidence of atrial fibrillation or flutter and supraventricular tachycardia.
Pair of Trials Demonstrate Reveal LINQ's Ability to Improve Detection of Atrial Fibrillation
June 03, 2021
Simultaneously published in JAMA, the PER DIEM and STROKE-AF trials demonstrate the ability of Medtronic's insertable cardiac monitor, Reveal LlNQ, to improve detection of atrial fibrillation in patients with a history of stroke.
Meta-Analysis Details CVD Risk After Thyroidectomy in Patients with Thyroid Cancer
June 03, 2021
Data from AACE 2021 suggests the risk of cardiovascular disease was 15% greater among patients with thyroid cancer who underwent thyroidectomy than the general population, but found no significant difference in risk of cardiac mortality and atrial fibrillation.
FIDELIO-DKD Analysis Finds Finerenone Reduces Risk of New-Onset AFib
May 17, 2021
An analysis of FIDELIO-DKD indicates use of finerenone was associated with significant reductions in risk of new-onset atrial fibrillation in patients with type 2 diabetes and chronic kidney disease.
Cryoablation Bests Antiarrhythmic Drugs for Quality of Life in AFib Patients
May 15, 2021
An analysis of STOP AF First presented at ACC.21 details the quality of life improvements observed with cryoablation versus antiarrhythmic drugs as initial treatment for atrial fibrillation.